Physician profile
Justin J Fleming
NPI 1043319122
$1,235,144.05
in general payments reported to CMS, 2019-2025
16 companies · $291K in 2025
The $291K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160K · 2020: $134K · 2021: $143K · 2022: $151K · 2023: $158K · 2024: $198K · 2025: $291K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $334K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200K · Consulting Fee: $80K · Travel and Lodging: $26K · Food and Beverage: $6,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $334,105.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $199,520.25 |
| Consulting Fee | $80,309.32 |
| Travel and Lodging | $26,382.97 |
| Food and Beverage | $6,938.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,228,300.75 | 2019-2025 | Arthrex, Distal Extremities Implants Trauma |
| Seapearl East, INC | $3,049.90 | 2019-2025 | |
| Stryker Corporation | $1,708.92 | 2021-2025 | Inbone, Augment Injectable, Variax |
| Wright Medical Technology, INC. | $895.82 | 2019 | |
| Paragon 28, INC. | $312.07 | 2022-2024 | Silverback |
| Exactech, INC. | $174.63 | 2023 | |
| Pinnacle, INC | $120.56 | 2019 | |
| Eclipse Technology Solutions INC. | $118.36 | 2025 | |
| Organogenesis INC. | $106.30 | 2020 | |
| Cerapedics INC. | $98.99 | 2022 | |
| Impactortho, INC. | $81.47 | 2024 | |
| Depuy Synthes Sales INC. | $52.61 | 2021 | |
| Acumed LLC | $51.36 | 2019 | |
| Kerecis Limited | $43.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Nuvasive, INC. | $16.06 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.